 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Committee of the Board (the 'Committee') of Aarey Drugs & Pharmaceuticals Ltd at its meeting held today has passed the following in connection with the Issue:
- Approved the issue price of Rs. 54.93/- per Equity share ( including premium of Rs. 44.93/- per Equity share) for issuance & allocation of 33,00,000 Equity shares to eligible Qualified Institutional Buyers in the Qualified Institutional Placement, aggregating to Rs. 1,812.69 Lakhs.
- Approved and adopted the Placement document dated March 20, 2018, in connection with the Issue, (the " Placement Document").
- Approved the issue of confirmation of allocation notes to Qualified Institutional Buyers.
Shares of AAREY DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs.52.45 as compared to the previous close of Rs. 52.55. The total number of shares traded during the day was 180151 in over 247 trades.
The stock hit an intraday high of Rs. 53.9 and intraday low of 51. The net turnover during the day was Rs. 9499545.